A Phase 1 Study of PAmAb, a Fully Human Monoclonal Antibody against Bacillus anthracis Protective Antigen, in Healthy Volunteers - Concepedia

Concepedia

Publication | Open Access

A Phase 1 Study of PAmAb, a Fully Human Monoclonal Antibody against Bacillus anthracis Protective Antigen, in Healthy Volunteers

DOI Full Paper Access

93

Citations

9

References

2005

Year

G. Mani Subramanian, P. Cronin, Gerald E. Poley, Arthur Weinstein, Susan M. Stoughton, John Zhong, Y. Ou, J. F. Zmuda, Blaire L. Osborn, William W. Freimuth

Clinical Infectious Diseases

Abstract

PAmAb is safe, well tolerated, and bioavailable after a single intramuscular or intravenous dose, which supports further clinical development of PAmAb as a novel therapeutic agent for inhalational anthrax.

References

	Year	Citations

Page 1